Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs geared toward increasing the horizons of cytokine-based immunotherapy, specifically for cancers where cure alternatives remain limited. Use the links below to learn additional about our portfolio of cytokine-based immunotherapy candidates. Take a look at https://financefeeds.com/hashkey-appoints-chagri-poyraz-as-chief-risk-officer/